期刊文献+

减轻异基因造血干细胞移植GVHD增强GVT的研究

减轻异基因造血干细胞移植GVHD增强GVT的研究
下载PDF
导出
出处 《中国肿瘤临床与康复》 2007年第2期170-172,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
  • 相关文献

参考文献20

  • 1Sureda A,Schmitz N.Allogeneic stem cell transplantation after reduced-intensity conditioning in lymphoid malignancies[J].Ann Hematol,2003,82(1):1-13.
  • 2Capizzi RL.The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine[J].Semin Oncol,1999,26(2 Suppl 7):3-21.
  • 3Marmont AM,Horowitz MM,Gale RP,et al.T-cell depletion of HLA-identical transplants in leukemia[J].Blood,1991,78 (8):2120-2130.
  • 4Lowdell MW,Koh MB.Immunotherapy of AML:future directions[J].J Clin Pathol,2000,53 (1):49-54.
  • 5Zeiser R,Marks R,Bertz H,et al.Immunopathogenesis of acute graft-versus-host disease:implications for novel preventive and therapeutic strategies[J].Ann Hematol,2004,83(9):551-565.
  • 6Ferrara JL,Reddy P.Pathophysiology of graft-versus-host disease[J].Semin Hematol,2006,43 (1):3-10.
  • 7Goker H,Haznedaroglu IC,Chao NJ.Acute graft-vs-host disease:pathobiology and management[J].Exp Hematol,2001,29 (3):259-277.
  • 8Aglietta M,Bertolini F,Carlo-Stella C,et al.Ex vivo expansion of hematopoietic cells and their clinical use[J].Haematologica,1998,83(9):824-848.
  • 9Jung U,Foley JE,Erdmann AA,et al.CD3/CD28-costimulated T1 and T2 subsets:differential in vivo allosensitization generates distinct GVT and GVHD effects[J].Blood,2003,102(9):3439-3446.
  • 10McSweeney PA,Niederwieser D,Shizuru JA,et al.Hematopoietic cell transplantation in older patients with hematologic malignancies:replacing high-dose cytotoxic therapy with graft-versus-tumor effects.Blood[J],2001,97(11):3390-3400.

二级参考文献21

  • 1孟玉茹,黄平.淋巴因子激活的骨髓细胞或脾细胞对小鼠移植物抗宿主病的预…[J].中华血液学杂志,1993,14(11):564-566. 被引量:3
  • 2何金生,李瑞珠,宗庭益.MTT还原法检测NK细胞活性的方法学研究[J].中国免疫学杂志,1996,12(6):356-358. 被引量:124
  • 3董秀明 糜福顺 等.MTT法在放射生物学中的应用[J].中华放射医学与防护杂志,1991,11:234-237.
  • 4Shimoni A, Gajewski JA, Donato M, et al. Long-Term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation. Biol Blood Marrow Transplan
  • 5Lonnqvist B, Brune M, Ljungman P. Lymphoblastoid human interferon and low dose IL-2 combined with donor lymphocyte infusion as therapy of a third relapse of CML-a case report. Bone Marrow Transplant, 1996,18:241-242.
  • 6Kolb H J, Mittermuller J, Clemm C, et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood, 1990, 76: 2462-2465.
  • 7Leis J, Porter D L. Unrelated donor leukocyte infusions to treat relapse after unrelated donor bone marrow transplantation. Leuk Lymphoma, 2002,43: 9 - 17.
  • 8Laws H J,Nurnberger W,Korholz D, et al. Successful treatment of relapsed CML after cord blood transplantation with donor leukocyte infusion IL-2 and IFNalpha.Bone Marrow Transplant, 2000,25: 219 - 222.
  • 9何金生,中国免疫学杂志,1996年,12卷,356页
  • 10孟玉茹,中华血液学杂志,1993年,14卷,564页

共引文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部